News
IceCure (ICCM) Q2 2025 Earnings Call Transcript
Revenue -- Revenue (GAAP) totaled approximately $1.25 million for the six months ended June 30, 2025, down from $1.75 million in 2024, including over $200,000 in shipments delayed in Q2 2025 due to the Israeli-Iran conflict; this revenue is expected to be recognized in Q3 2025.
For 2Q, Macquarie Diversified Income Fund Institutional Class shares outperformed the Fund’s benchmark, the Bloomberg US ...
Tencent reported second-quarter revenue growth of 15% on Wednesday, driven by robust gaming performance and AI-powered ...
Primo Brands Corporation (NYSE:PRMB) is one of the best upside stocks to invest in now. On August 11, Morgan Stanley lowered ...
For 2Q25, Macquarie Corporate Bond Fund Institutional Class shares underperformed the Fund’s benchmark, the Bloomberg US ...
Revenue (GAAP) dropped 41.6% from Q2 2024 to Q2 2025, coming in below analyst expectations for the quarter. Rigetti launched the industry’s largest multichip quantum computer, hitting a key technology ...
Cytokinetics Incorporated (NASDAQ:CYTK) is one of the best upside stocks to invest in now. On August 8, Citi lowered the firm ...
Bally’s Corporation’s company-wide second quarter revenues rose 5.8% over the same period last year. Its total revenue of $657.5 million exceeded analysts’ estimates. Key In ...
The New York-based Eastman Kodak company says there's "substantial doubt" over its future after 2025's second-quarter ...
Strong Results Reflect Rising Demand, Business Growth, and Strategic Investments Amid Saudi Arabia’s Accelerating Energy ...
Australia's annual wage growth steadied in the June quarter after more than a year of declines, led in large part by gains in ...
During the quarter, Voya Global Equity Dividend And Premium Opportunity Fund underperformed its Index largely due to beta ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback